BE FIRST.
De-risk R&D decisions and increase the likelihood of success of first-in-class drug candidates.
The Advantage of High-Content Imaging
With our multiplexed, high content imaging-based phenotypic assays, you get the quantitative data and biological insights needed to more confidently answer high-stakes questions related to targets and drug candidates.
New Insights for Your Disease Area
FIBROSIS
Investigate your drug candidates' effects on fibrotic inhibition and induction.
NEUROBIOLOGY
Overcome the challenges of CNS-related research and gain insights into your drug candidates.
ONCOLOGY & IMMUNO-ONCOLOGY
Advance your drug-development campaigns with biologically relevant systems.
WELCOME TO PHENOVISTA
WHAT SETS US APART
Unmatched Expertise in High-content Imaging & Analysis
We use state-of-the-art imaging instrumentation and advanced, in-house informatics to answer complex biological questions. With our custom and Ready-2-Go assays, clients get high-quality, quantitative functional, structural, and mechanistic data for unprecedented insights.
Experience Designing & Performing Difficult Biological Assays
Our team of scientists has diverse expertise ranging from biomedical engineering to neurobiology. We also have extensive experience working with primary cells, iPSC-derived neurons and glia, and client-engineered lines in a variety of formats such as 2D, 3D, co-culture, and microfluidic systems.
A Commitment to Collaboration
We work with our clients from around the world in a collaborative, adaptable manner to design and implement physiologically meaningful assays to help answer their unique biological questions.
YOUR COLLABORATIVE DISCOVERY PARTNER
Trusted by biotech and pharmaceutical companies around the world.
WHAT SETS US APART
Our team of predominantly PhD-level scientists has diverse expertise ranging from biomedical engineering to neurobiology. We work with clients in a collaborative, adaptable manner to design and implement physiologically meaningful assays to help answer their biological questions. Our team’s repertoire includes working with primary cells, iPSC-derived neurons and glia, and client-engineered lines in a variety of formats such as 2D, 3D, co-culture, and microfluidic systems. Our team delivers unique and cutting-edge functional, structural, and pre-clinical, mechanistic data to clients globally.
RESOURCES
Practical Considerations for Designing and Executing High-content Screens
Learn about the basic principles and process of high-content screening with tips on how to design a successful assay.
Speaker: James G. Evans, PhenoVista CEO
Using In Vitro Assays to Model Complex Biology with PhenoVista's Assay Services
Learn how expertise in developing complex, in vitro studies to provide actionable and relevant data can help drive drug discovery forward.
Speaker: Ana Wang, PhD, Product Manager